Hospitalisation admission analysis of HBsAg and HBcAb positive subjects with general population controls
| HBsAg positive cases and controls | HBcAb positive cases and controls | |||
|---|---|---|---|---|
| Hospital admission variable | Cases (n) | Controls (n) | Cases (n) | Controls (n) |
| ap<0.05; bp=0.051; cp=0.015, Wilcoxon test of significance. | ||||
| HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; HBcAB, hepatitis B core antibody. | ||||
| A No of patients | 187 | 374 | 331 | 662 |
| B No of patients admitted | 117 | 222 | 200 | 8 |
| C No of admissions | 574 | 595 | 1346 | 36 |
| D No hospital admission reported | 70 | 151 | 131 | 654 |
| Average number of hospital admissions (C/A) | 3.1 | 1.6 | 4 | 0.05 |
| Readmissions to hospital per patient (C−B)/B | 3.9 | 1.7 | 6 | 1 |
| Discharged to | ||||
| Home | 480 | 546 | 1201 | 36 |
| Died in hospital | 11 | 3 | 41 | 0 |
| Other (transfer to other hospital) | 28 | 14 | 104 | 0 |
| Length of stay (LOS) | ||||
| Average LOS per hospital stay (days) | 7.07 (12.78) | 6.06 (11.90) | 7.49 (12.33) | 5.25 (6.0) |
| Median (range) (days) | 3 (1–138) | 3 (1–184)b | 4 (1–237) | 3 (1–23)b |
| E Total cost of admitted cases | £1 024 601 | £947 749 | £2 695 223 | £37 920 |
| Average cost per patient (E/A) | £5479 | £2540 | £10 5 28 | £91a |
| Average cost per patient admitted (E/B) | £8757 | £4269 | £13 4 76 | £7558 |
| Average cost per admission (E/C) | £1785 | £1596 | £2002 | £1053 |
| Median cost per patient admitted | £2810 | £1579a | £5570 | £5003 |
| Median cost per patient | £847 | £263c | £2933 | £1a |